The role of sialoglycans in modulating dendritic cell function and tumour immunity.
Anti-tumour immunity
Cancer
Dendritic cells
Immunotherapy
Mucins
Sialoglycans
Journal
Seminars in immunology
ISSN: 1096-3618
Titre abrégé: Semin Immunol
Pays: England
ID NLM: 9009458
Informations de publication
Date de publication:
25 Oct 2024
25 Oct 2024
Historique:
received:
01
09
2024
revised:
15
10
2024
accepted:
15
10
2024
medline:
27
10
2024
pubmed:
27
10
2024
entrez:
26
10
2024
Statut:
aheadofprint
Résumé
Dendritic cells (DCs) are crucial for initiating immune responses against tumours by presenting antigens to T cells. Glycosylation, particularly sialylation, plays a significant role in regulating cell functions, by modulating protein folding and signalling. This review aimed to provide a comprehensive overview of how sialic acids influence key aspects of DC biology, including maturation, migration, antigen presentation, and T cell interactions. Sialic acids influence DC endocytosis, affecting their ability to uptake and present antigens, while guiding their migration to lymph nodes and inflamed tissues. Removing sialic acids enhances DC-mediated antigen presentation to T cells, potentially boosting immune responses. Additionally, sialylated glycans on DCs modulate immune checkpoints, which can impact tumour immunity. Hypersialylation of tumour mucins further promotes immune evasion by interacting with DCs. Understanding the interplay between sialylation and DC functions offers promising avenues for enhancing cancer immunotherapy.
Identifiants
pubmed: 39461124
pii: S1044-5323(24)00038-1
doi: 10.1016/j.smim.2024.101900
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
101900Informations de copyright
Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.